Skip to content
TrialScanner

NCT06029439

Study to Assess the Safety and Effectiveness of NMRA-335140-501

Phase 3TerminatedNMRALead

Registry record

Lead sponsor
Neumora Therapeutics, Inc.
Conditions
Major Depressive Disorder
Primary completion
Aug 17, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06029439 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.